In recent years, a new anticoagulant drug called Xarelto (rivaroxaban) has been found by the FDA to increase the risk for major bleeding events over other drugs in its class.  And unlike other drugs in its class, the manufacturer does not recommend regular blood testing, a simple procedure which can lower the risk for major bleeding events by 40%.  Here, we discuss one piece of research titled “New oral anticoagulants in the treatment of acute venous thromboembolism – a systematic review with indirect comparisons.” on risks associated with Xarelto by an Austrian research team, published in VASA (2014).

The team studied over 27,000 patients using a variety of anticoagulants and measured the risk for stroke and bleeding events, finding that “Regarding occurrence of the composite bleeding endpoint, apixaban performed better than all other NOACs and dabigatran better than rivaroxaban and edoxaban.”

Concluding that “Indirect comparisons indicate differences in the risk of clinically relevant bleeding events” and “Important issues such as monitoring and reversal of anticoagulation are still unresolved,” (emphasis added) this research sheds lights on missteps by Xarelto’s manufacturer.  Because there is no reversal agent for Xarelto, patients using this drug who enter the emergency room cannot undergo surgery until the drug is metabolized sufficiently, causing myriad medical issues.

So, because Bayer Pharmaceuticals, Inc. failed time and again to adequately inform patients of the need for testing and the risk for bleeding linked to Xarelto, Xarelto lawsuits are currently being filed in great number.

If you or a loved one used Xarelto and suffered a major bleeding event, you may be entitled to significant financial compensation from the manufacturer.  For a free, no-obligation case consultation, contact our team of Xarelto lawyers at the information provided below.  We have the compassion, experience, and resources necessary to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

Our Xarelto Lawsuit Information page is a great place to start if you have any questions about Xarelto.